{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:57:20Z","timestamp":1791118640418,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002367","name":"Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002367","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002843","name":"Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.vaccine.2014.03.012","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T06:31:16Z","timestamp":1395383476000},"page":"2406-2412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses"],"prefix":"10.1016","volume":"32","author":[{"given":"Yicun","family":"Cai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingwei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qibin","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"August (8)","key":"10.1016\/j.vaccine.2014.03.012_bib0005","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1017\/S0950268809991555","article-title":"Human enterovirus 71 and hand, foot and mouth disease","volume":"138","author":"Wong","year":"2010","journal-title":"Epidemiol Infect"},{"issue":"8","key":"10.1016\/j.vaccine.2014.03.012_bib0010","doi-asserted-by":"crossref","first-page":"e1737","DOI":"10.1371\/journal.pntd.0001737","article-title":"Challenges to licensure of enterovirus 71 vaccines","volume":"6","author":"Lee","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.03.012_bib0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.47102\/annals-acadmedsg.V38N2p106","article-title":"Epidemiology and control of hand, foot and mouth disease in Singapore, 2001\u20132007","volume":"38","author":"Ang","year":"2009","journal-title":"Ann Acad Med Singapore"},{"issue":"November (11)","key":"10.1016\/j.vaccine.2014.03.012_bib0020","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"November (2)","key":"10.1016\/j.vaccine.2014.03.012_bib0025","article-title":"Coxsackievirus A16: Epidemiology, diagnosis, and vaccine","volume":"10.","author":"Mao","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2014.03.012_bib0030","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00006454-199912000-00013","article-title":"Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998","volume":"18","author":"Chang","year":"1999","journal-title":"Pediatr Infect Dis J"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.03.012_bib0035","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1128\/JCM.00718-06","article-title":"Genetic diversity of coxsackievirus A16 associated with hand, foot, and mouth disease epidemics in Japan from 1983 to 2003","volume":"45","author":"Hosoya","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"July (4)","key":"10.1016\/j.vaccine.2014.03.012_bib0040","doi-asserted-by":"crossref","first-page":"254","DOI":"10.7883\/yoken.JJID.2009.254","article-title":"Genetic changes of coxsackievirus A16 and enterovirus 71 isolated from hand, foot, and mouth disease patients in Toyama, Japan between 1981 and 2007","volume":"62","author":"Iwai","year":"2009","journal-title":"Jpn J Infect Dis"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2014.03.012_bib0045","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1574-6976.2002.tb00601.x","article-title":"An overview of the evolution of enterovirus 71 and its clinical and public health significance","volume":"26","author":"McMinn","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0050","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/1743-422X-8-534","article-title":"Construction and characterization of an infectious clone of coxsackievirus A16","volume":"8","author":"Liu","year":"2011","journal-title":"Virol J"},{"issue":"11","key":"10.1016\/j.vaccine.2014.03.012_bib0055","doi-asserted-by":"crossref","first-page":"e49973","DOI":"10.1371\/journal.pone.0049973","article-title":"Immunological and biochemical characterization of coxsackie virus A16 viral particles","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.vaccine.2014.03.012_bib0060","doi-asserted-by":"crossref","first-page":"e20005","DOI":"10.1371\/journal.pone.0020005","article-title":"Purification and characterization of enterovirus 71 viral particles produced from vero cells grown in a serum-free microcarrier bioreactor system","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS ONE"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.03.012_bib0065","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1097\/INF.0b013e3181a41d63","article-title":"Diseases caused by enterovirus 71 infection","volume":"28","author":"Lee","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2014.03.012_bib0070","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM196305092681904","article-title":"Fatal infection in an infant associated with Coxsackie virus group A, type 16","volume":"268","author":"Wright","year":"1963","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0075","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(63)80047-5","article-title":"Myocarditis possibly due to Coxsackie group A, type 16, virus","volume":"May (62)","author":"Goldberg","year":"1963","journal-title":"J Pediatr"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.03.012_bib0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/01.inf.0000115950.63906.78","article-title":"Fatal coxsackievirus A16 infection","volume":"23","author":"Wang","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"July (7)","key":"10.1016\/j.vaccine.2014.03.012_bib0085","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3201\/eid1307.070295","article-title":"Fatal coxsackievirus A-16 pneumonitis in adult","volume":"13","author":"Legay","year":"2007","journal-title":"Emerg Infect Dis"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2014.03.012_bib0090","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.3201\/eid1510.090594","article-title":"Rhombencephalitis and coxsackievirus A16","volume":"15","author":"Goto","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2014.03.012_bib0095","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1743-422X-9-8","article-title":"Distribution of enteroviruses in hospitalized children with hand, foot and mouth disease and relationship between pathogens and nervous system complications","volume":"9","author":"Xu","year":"2012","journal-title":"Virol J"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.03.012_bib0100","first-page":"339","article-title":"Analysis on the epidemiological and genetic characteristics of enterovirus type 71 and Coxsackie A16 virus infection in Jiangsu, China","volume":"30","author":"Pan","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"issue":"October (5)","key":"10.1016\/j.vaccine.2014.03.012_bib0105","first-page":"334","article-title":"To investigate pathogen of hand, foot and mouth disease in Shenzhen in 2008","volume":"23","author":"Zhang","year":"2009","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0110","first-page":"3341","article-title":"Severe hand-foot-and-mouth disease caused by mixed infection of enterovirus 71 and coxsackie A16: reports of 6 cases","volume":"29","author":"Zhang","year":"2011","journal-title":"Chinese General Practice"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2014.03.012_bib0115","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s00705-010-0722-0","article-title":"Emergence of enterovirus 71 double-recombinant strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV71","volume":"155","author":"Yip","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/1743-422X-7-94","article-title":"An emerging recombinant human enterovirus 71 responsible for the 2008 outbreak of hand foot and mouth disease in Fuyang city of China","volume":"7","author":"Zhang","year":"2010","journal-title":"Virol J"},{"issue":"May (22)","key":"10.1016\/j.vaccine.2014.03.012_bib0125","doi-asserted-by":"crossref","first-page":"3778","DOI":"10.1016\/j.vaccine.2010.02.095","article-title":"The global introduction of inactivated polio vaccine can circumvent the oral polio vaccine paradox","volume":"28","author":"Heinsbroek","year":"2010","journal-title":"Vaccine"},{"issue":"April (20)","key":"10.1016\/j.vaccine.2014.03.012_bib0130","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.1016\/j.vaccine.2010.03.003","article-title":"EV71: an emerging infectious disease vaccine target in the Far East?","volume":"28","author":"Xu","year":"2010","journal-title":"Vaccine"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.03.012_bib0135","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1586\/erv.09.152","article-title":"Development of enterovirus 71 vaccines","volume":"9","author":"Lee","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"March (1)","key":"10.1016\/j.vaccine.2014.03.012_bib0140","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s11684-012-0237-z","article-title":"Progress on the research and development of human enterovirus 71 (EV71) vaccines","volume":"7","author":"Liang","year":"2013","journal-title":"Front Med"},{"issue":"June (9882)","key":"10.1016\/j.vaccine.2014.03.012_bib0145","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(13)61049-1","article-title":"Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"381","author":"Zhu","year":"2013","journal-title":"Lancet"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2014.03.012_bib0150","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.vaccine.2013.03.007","article-title":"Active immunization with a Coxsackievirus A16 experimental inactivated vaccine induces neutralizing antibodies and protects mice against lethal infection","volume":"31","author":"Cai","year":"2013","journal-title":"Vaccine"},{"issue":"November (22)","key":"10.1016\/j.vaccine.2014.03.012_bib0155","doi-asserted-by":"crossref","first-page":"11967","DOI":"10.1128\/JVI.00902-12","article-title":"A neonatal mouse model of coxsackievirus A16 for vaccine evaluation","volume":"86","author":"Mao","year":"2012","journal-title":"J Virol"},{"issue":"April (1)","key":"10.1016\/j.vaccine.2014.03.012_bib0160","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jviromet.2011.01.016","article-title":"Detection, characterization and quantitation of coxsackievirus A16 using polyclonal antibodies against recombinant capsid subunit proteins","volume":"173","author":"Liu","year":"2011","journal-title":"J Virol Methods"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.03.012_bib0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.jviromet.2012.09.024","article-title":"Characterization of enterovirus 71 capsids using subunit protein-specific polyclonal antibodies","volume":"187","author":"Liu","year":"2013","journal-title":"J Virol Methods"},{"issue":"December (1\u20132)","key":"10.1016\/j.vaccine.2014.03.012_bib0170","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jviromet.2012.06.025","article-title":"Development of murine monoclonal antibodies with potent neutralization effects on enterovirus 71","volume":"186","author":"Ku","year":"2012","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0175","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/1743-422X-8-306","article-title":"Neutralizing antibody response in the patients with hand, foot and mouth disease to enterovirus 71 and its clinical implications","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0180","first-page":"493","article-title":"A simple method of estimating 50 percent endpoints","volume":"27","author":"Reed","year":"1938","journal-title":"Am J Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2014.03.012_bib0185","doi-asserted-by":"crossref","first-page":"e57601","DOI":"10.1371\/journal.pone.0057601","article-title":"Neutralizing antibodies induced by recombinant virus-like particles of enterovirus 71 genotype C4 inhibit infection at pre- and post-attachment steps","volume":"8","author":"Ku","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2014.03.012_bib0190","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1743-422X-8-508","article-title":"Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009","volume":"8","author":"Yang","year":"2011","journal-title":"Virol J"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2014.03.012_bib0195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0092-1157(88)90014-5","article-title":"Interference between strains in live virus vaccines. I. Combined vaccination with measles, mumps and rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"J Biol Stand"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2014.03.012_bib0200","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/0092-1157(88)90015-7","article-title":"Interference between strains in live virus vaccines. II. Combined vaccination with varicella and measles\u2013mumps\u2013rubella vaccine","volume":"16","author":"Berger","year":"1988","journal-title":"J Biol Stand"},{"issue":"6","key":"10.1016\/j.vaccine.2014.03.012_bib0205","first-page":"695","article-title":"Oral immunization against poliomyelitis","volume":"23","author":"Payne","year":"1960","journal-title":"Bull World Health Organ"},{"issue":"September\u2013October (5)","key":"10.1016\/j.vaccine.2014.03.012_bib0210","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1093\/clinids\/13.5.926","article-title":"Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review","volume":"13","author":"Patriarca","year":"1991","journal-title":"Rev Infect Dis"},{"issue":"February (2)","key":"10.1016\/j.vaccine.2014.03.012_bib0215","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4269\/ajtmh.2009.80.302","article-title":"Evaluation of interferences between dengue vaccine serotypes in a monkey model","volume":"80","author":"Guy","year":"2009","journal-title":"Am J Trop Med Hyg"},{"issue":"August (3)","key":"10.1016\/j.vaccine.2014.03.012_bib0220","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1093\/infdis\/jir279","article-title":"Interference and facilitation between dengue serotypes in a tetravalent live dengue virus vaccine candidate","volume":"204","author":"Anderson","year":"2011","journal-title":"J Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.03.012_bib0225","doi-asserted-by":"crossref","first-page":"264","DOI":"10.4269\/ajtmh.2002.66.264","article-title":"Safety and immunogenicity of tetravalent live-attenuated dengue vaccines in Thai adult volunteers: role of serotype concentration, ratio, and multiple doses","volume":"66","author":"Sabchareon","year":"2002","journal-title":"Am J Trop Med Hyg"},{"issue":"December (6 Suppl.)","key":"10.1016\/j.vaccine.2014.03.012_bib0230","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4269\/ajtmh.2003.69.6_suppl.0690024","article-title":"Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates","volume":"69","author":"Sun","year":"2003","journal-title":"Am J Trop Med Hyg"},{"issue":"February (9)","key":"10.1016\/j.vaccine.2014.03.012_bib0235","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.vaccine.2005.09.029","article-title":"Immunogenicity and safety of two live-attenuated tetravalent dengue vaccine formulations in healthy Australian adults","volume":"24","author":"Kitchener","year":"2006","journal-title":"Vaccine"},{"issue":"November\u2013December (6)","key":"10.1016\/j.vaccine.2014.03.012_bib0240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/rmv.405","article-title":"Antibody-dependent enhancement of viral infection: molecular mechanisms and in vivo implications","volume":"13","author":"Takada","year":"2003","journal-title":"Rev Med Virol"},{"issue":"January (4)","key":"10.1016\/j.vaccine.2014.03.012_bib0245","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.vaccine.2008.10.087","article-title":"Vaccine-induced enhancement of viral infections","volume":"27","author":"Huisman","year":"2009","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14003569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14003569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T07:19:56Z","timestamp":1689059996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14003569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":49,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0264410X14003569"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.012","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.03.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}